Get startedLog in
    Picture of Radiopharm Theranostics logo

    RAD — Radiopharm Theranostics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart

    Picture of Radiopharm Theranostics logoRadiopharm Theranostics
    24/02/2026 13:02
    Feb 24 (Reuters) - Radiopharm Theranostics Ltd RAD.AX:

RADIOPHARM THERANOSTICS DOSES FIRST PATIENT IN PHASE 1/2A CLINICAL STUDY OF BETABART (RV-01)

Source text: ID:nGNX2dGvwX

Further company coverage: RAD.AX

 (((( Reuters.briefs@thomsonreuters.com ;));))

    Recent news on Radiopharm Theranostics

    See all news